Gemcitabine and cisplatin combination chemotherapy as first-line treatment in patients with metastatic breast cancer.

被引：0
|
作者：
Alauddin, Z [1 ]
Shaharyar, A [1 ]
机构：
[1] Mayo Hosp, King Edward Med Coll, Lahore, Pakistan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：56S / 56S
页数：1
相关论文
共 50 条
  • [21] Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
    Wilbur, H. Catherine
    Durham, Jennifer N.
    Lim, Su Jin
    Purtell, Katrina
    Bever, Katherine M.
    Laheru, Daniel A.
    De Jesus-Acosta, Ana
    Azad, Nilofer S.
    Wilt, Bradley
    Diaz, Luis A.
    Le, Dung T.
    Wang, Hao
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (08): : 1672 - 1677
  • [22] Docetaxel, cisplatin and gemcitabine as first line for patients with advanced/metastatic head and neck cancer.
    Kouroussis, CH
    Androulakis, N
    Boukovinas, J
    Agelaki, S
    Vamvakas, L
    Syrigos, K
    Potamianou, A
    Christophillakis, CH
    Tselepatiotis, E
    Helis, L
    Polyzos, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 521S - 521S
  • [23] Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer
    Sánchez-Rovira, P
    Jaén, A
    González, E
    Porras, I
    Dueñas, R
    Medina, B
    Mohedano, N
    Fernández, M
    Martos, M
    Lozano, A
    Carrasco, E
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 44 - 47
  • [24] Apatinib in combination with docetaxel and S1 chemotherapy in the first-line treatment of metastatic gastric cancer.
    Xia, Ling
    Gao, Yu
    Gong, Jun
    Dai, Jing
    Peng, Jin
    He, Lilin
    Chen, Weidong
    Gong, Wei
    Yang, Lei
    Wang Wen-Bo
    Jiang, Huangang
    Xu, Hui
    Wang, Qing-Yun
    Wu, Han
    Wang, You
    Wu, Lu
    Zhou, Fuxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer
    Vrdoljak, E.
    Boban, M.
    Omrcen, T.
    Hrepic, D.
    Fridl-Vidas, V.
    Boskovic, L.
    NEOPLASMA, 2011, 58 (02) : 172 - 178
  • [26] First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapyvscombination chemotherapy
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (18) : 4022 - 4033
  • [27] Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer
    Baltali, E
    Altundag, MK
    Güler, N
    Özisik, Y
    Firat, D
    Baran, I
    Tekuzman, G
    TUMORI, 2002, 88 (03) : 200 - 203
  • [28] Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
    Chan, A.
    Miles, D. W.
    Pivot, X.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2305 - 2315
  • [29] Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer
    Delfino, C
    Caccia, G
    Gonzáles, LR
    Mickiewicz, E
    Rodger, J
    Balbiani, L
    Morales, DF
    Comba, AZ
    Brosio, C
    ONCOLOGY, 2004, 66 (01) : 18 - 23
  • [30] Impact of chemotherapy beyond the first line in patients with metastatic breast cancer.
    Dufresne, A.
    Pivot, X.
    Colin, P.
    Bosset, M.
    Tournigand, C.
    Alwegg, T.
    De Grammont, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S280 - S281
12345